Omada Health
OMDA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | |
|---|---|---|---|
| Market Cap | $1,282,120 | $1,282,120 | $1,282,120 |
| - Cash | $76,392 | $115,643 | $168,123 |
| + Debt | $30,186 | $30,580 | $30,809 |
| Enterprise Value | $1,235,914 | $1,197,057 | $1,144,806 |
| Revenue | $169,800 | $122,784 | $89,185 |
| % Growth | 38.3% | 37.7% | – |
| Gross Profit | $102,877 | $69,971 | $42,791 |
| % Margin | 60.6% | 57% | 48% |
| EBITDA | -$37,828 | -$58,358 | -$63,986 |
| % Margin | -22.3% | -47.5% | -71.7% |
| Net Income | -$47,137 | -$67,511 | -$72,518 |
| % Margin | -27.8% | -55% | -81.3% |
| EPS Diluted | -0.85 | -1.21 | -1.3 |
| % Growth | 29.8% | 6.9% | – |
| Operating Cash Flow | -$34,179 | -$49,738 | -$68,980 |
| Capital Expenditures | -$3,863 | -$2,921 | -$2,721 |
| Free Cash Flow | -$38,042 | -$52,659 | -$71,701 |